Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dimensional Fund Advisors Ltd. : Form 8.3 - UNITE GROUP PLC/THE - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
-
Notified to Sponsor Third Annual ORY APAC-US Conference 2025 in Singapore
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
Form 8.3 - AXA INVESTMENT MANAGERS: Alpha Group International plc
-
Bitget Wallet Partners with Mastercard and Immersve to Introduce Zero-Fee Crypto Card
-
TRREB: More Interest Rate Cuts and a Trade Deal Would Further Improve Home Sales
-
BIC: Half-Year Liquidity Contract Statement
-
On the selection process for the new Supervisory Board term at AB “Ignitis grupė”
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc.
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
Form 8.5 (EPT/RI) - Ricardo Plc
-
Registration of share consolidation (reverse split) in IDEX Biometrics - 4 July 2025
-
Man Group PLC : Form 8.3 - Deliveroo Plc
-
Form 8.5 (EPT/RI) - FD Technologies plc
-
THEON accelerates strategic expansion in the Baltic Region
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Miss Universe Guyana Appoints Ivonn Novikova as New Assistant Director
-
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
-
Regarding the approval of INVL Technology prospectus
-
Fixing of interest rate and refinancing triggers
-
Syensqo - Participation notification by BlackRock Inc.
-
Bekaert - Update on the Share Buyback Program and Liquidity Agreement
-
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
-
Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025
-
NBPE - Transaction in Own Shares
-
Eurocastle Releases First Quarter 2025 Interim Management Statement, Release of Liquidation Reserves and Notice of Annual General Meeting
-
NBPE - 2H 2025 Dividend Declaration
-
Transaction in Own Shares
-
IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 4 July 2025
-
Alstom to supply M-9A railcars to the New York Metropolitan Transportation Authority for €2.0 billion
-
ISS wins large contract with public healthcare institution in Austria
-
Start of Day Message
-
Air France-KLM initiates proceedings to take a majority stake in SAS
-
Bitget Wallet Cuts Onchain TRON USDT Fees by 50% with GetGas Upgrade
-
Lerøy Seafood Group ASA: Trading update Q2 2025
-
Starlight Retail Joins Google Cloud Partner Advantage Program to Deliver Advanced Cloud and AI Solutions in Pakistan
-
WHEN LIGHT COMES UNEXPECTED: Clean Historical Fiction With Faith at the Center and Family at the Heart
-
Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale
-
BetterAlt Partners with Sprouts Farmers Market to Expand Retail Presence Nationwide
-
Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in June 2025 of 0.6% Compared to 2024
-
World Trading Tournament Reschedules Main Event to March 2026 and Announces Official Mini Tournament Series
-
Special Needs Network Condemns Deep Federal Cuts to Medicaid, Food Assistance
-
Demo Copy now available on desktop — Start copying Lead Traders in a simulated trading environment
-
AlphaGen Announces Proposed Debt Settlement
